Physician profile
Judy D Risch
NPI 1568449155
$1,475.57
in general payments reported to CMS, 2019-2025
21 companies · $50.43 in 2025
The $50.43 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $183 · 2021: $154 · 2022: $333 · 2023: $153 · 2024: $138 · 2025: $50.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $558.58 | 2019-2022 | |
| Abbvie INC. | $139.67 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $119.85 | 2022-2023 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.73 | 2019-2021 | |
| Glaukos Corporation | $88.72 | 2019-2024 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Idose |
| Novartis Pharmaceuticals Corporation | $83.56 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $82.42 | 2022-2025 | Vyzulta, Miebo, Lotemax Sm |
| Alcon Vision LLC | $58.68 | 2022-2024 | Clareon, Rocklatan |
| Harrow Eye, LLC | $39.14 | 2024-2025 | Triesence, Iheezo, Vevye |
| Omeros Corporation | $37.55 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $21.68 | 2024 | Tecnis Simplicity |
| Kala Pharmaceuticals, INC. | $18.21 | 2021 | |
| New World Medical,INC. | $16.96 | 2021 | |
| Aerie Pharmaceuticals, INC. | $16.68 | 2020 | |
| Mallinckrodt Hospital Products INC. | $14.85 | 2024 | Acthar |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $14.34 | 2023 | Syfovre |
| Eyepoint US, INC. | $14.26 | 2019 | |
| Shire North American Group INC | $13.99 | 2019 | |
| Oyster Point Pharma, INC. | $13.27 | 2022 | |
| Lensar, INC. | $9.53 | 2020 | |
| Biotissue Holdings INC. | $0.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Risch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.